Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Debt to Equity (2021 - 2024)

Biofrontera (BFRI) has 4 years of Debt to Equity data on record, last reported at $0.03 in Q2 2024.

  • For Q2 2024, Debt to Equity changed N/A year-over-year to $0.03; the TTM value through Jun 2024 reached $0.03, changed N/A, while the annual FY2023 figure was $0.81, 180.17% up from the prior year.
  • Debt to Equity reached $0.03 in Q2 2024 per BFRI's latest filing, up from -$0.43 in the prior quarter.
  • Across five years, Debt to Equity topped out at $6.95 in Q3 2023 and bottomed at -$0.43 in Q1 2024.
  • Average Debt to Equity over 4 years is $1.06, with a median of $0.29 recorded in 2021.
  • Peak YoY movement for Debt to Equity: skyrocketed 4741.7% in 2023, then plummeted 203.58% in 2024.
  • A 4-year view of Debt to Equity shows it stood at $0.29 in 2021, then rose by 1.67% to $0.29 in 2022, then soared by 180.17% to $0.81 in 2023, then crashed by 96.67% to $0.03 in 2024.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.03 in Q2 2024, -$0.43 in Q1 2024, and $0.81 in Q4 2023.